Page 33 - 南京医科大学自然版
P. 33
第45卷第4期 郝沁敏,贾亦真,李 海,等. 基于CT 上肿瘤⁃胸膜位置关系预测肺腺癌患者隐匿性纵隔淋巴
2025年4月 结转移的临床价值[J]. 南京医科大学学报(自然科学版),2025,45(4):463-470 ·469 ·
纵隔胸膜淋巴网比非纵隔胸膜淋巴网要密集得 CA Cancer J Clin,2024,74(3):229-263
多。本文推测与纵隔胸膜毗邻的肺腺癌有更多的 [2] QIN S,SUN S,WANG Y,et al. Immune,metabolic land⁃
机会转移到纵隔淋巴结,但还需进一步的调查研究 scapes of prognostic signatures for lung adenocarcinoma
based on a novel deep learning framework[J]. Sci Rep,
来证实这些发现。
2024,14(1):527
本研究也存在一定局限性。首先,这是一项基
[3] KALVAPUDI S,VEDIRE Y,YENDAMURI S,et al. Neo⁃
于单一三级医院数据的回顾性研究,可能存在选择
adjuvant therapy in non ⁃ small cell lung cancer:basis,
偏倚。其次,CT 征象的评价是主观的,可能会出现 promise,and challenges[J]. Front Oncol,2023,13:
测量误差,特别是不规则的肿瘤大小和肿瘤的GGO 1286104
比例。最后,本研究没有包括一些淋巴结特征,如 [4] GOLDSTRAW P,CHANSKY K,CROWLEY J,et al. The
PET上的大小和max⁃suv。然而,本研究关注的是利 IASLC lung cancer staging project:proposals for revision
用原发性肺癌的 CT 特征来预测隐匿的纵隔淋巴结 of the TNM stage groupings in the forthcoming(eighth)
转移,而不是关注淋巴结特征本身。因此当遇到淋 edition of the TNM classification for lung cancer[J]. J
巴结自身特征模糊的患者时,本研究描述的肿瘤原 Thorac Oncol,2016,11(1):39-51
[5] HOY H,LYNCH T,BECK M. Surgical treatment of lung
发灶的其他影像学特征可能会有所帮助。
cancer[J]. Crit Care Nurs Clin North Am,2019,31(3):
综上所述,研究表明体积大、实性成分肿瘤、存
303-313
在胸膜牵拉和纵隔胸膜毗邻的肿瘤,有更高的隐匿 [6] 王 坤,田 辉. 隐匿性淋巴结转移在肺癌中的研究进
性纵隔淋巴结转移的风险,并且据此所建立的影像 展[J]. 临床肺科杂志,2023,28(2):249-253
特征模型有良好的预测效能。本研究所确定的隐 WANG K,TIAN H. Research progress of occult lymph
匿性纵隔淋巴结转移的预测因素,将帮助胸外科 node metastasis in lung cancer[J]. Journal of Clinical Pul⁃
医生在可切除的肺腺癌患者中选择更合适的治疗 monary Medicine,2023,28(2):249-253
方案。 [7] 吉木阿呷,庞玲玲,邹慎春,等. 支气管内超声引导下经血
利益冲突声明: 管针吸活检诊断肺门和纵隔病变的安全性和有效性[J].
所有作者声明无利益冲突。 中国内镜杂志,2024,30(6):83-88
Conflict of Interests: JIMU A,PANG L L,ZOU S C,et al. Safety and efficacy of
EBUS⁃TVNA technology in diagnosis of hilum of lung and
The authors report no conflicts of interest in this work.
mediastinal lesions[J]. China Journal of Endoscopy,
作者贡献声明:
郝沁敏负责实验设计、数据收集和初步分析,参与论文 2024,30(6):83-88
撰写;贾亦真数据收集、数据处理和统计分析,协助撰写论 [8] YOON H Y,LEE J C,KIM S W,et al. Prognosis of multi⁃
文;李海提供研究思路,指导数据分析;徐海提供研究思路, level N2⁃positive non⁃small cell lung cancer according to
指导数据分析;俞同福提供研究思路,指导数据分析;袁梅负 lymph node staging using endobronchial ultrasound⁃trans⁃
责研究的整体指导和论文的修改完善。 bronchial biopsy[J]. Thoracic Cancer,2018,9(6):684-
Author’s Contributions: 692
[9] CHEN Y S,LIN W H,LIN Y. Application of CT perfusion
HAO Qinmin was responsible for experimental design,data
imaging in NSCLC and its correlation with angiogenesis
collection,and preliminary analysis,and also participated in
and lymph node metastasis[J]. Eur Rev Med Pharmacol
writing the manuscript. JIA Yizhen handled data collection,data
Sci,2021,25(6):2511-2516
processing,and statistical analysis,and assisted in writing the
[10]YIN G,SONG Y,LI X,et al. Prediction of mediastinal
manuscript. LI Hai provided research ideas and guided the data
18
lymph node metastasis based on F⁃FDG PET/CT imag⁃
analysis. XU Hai also provided research ideas and guided the
ing using support vector machine in non⁃small cell lung
data analysis. YU Tongfu contributed research ideas and guided
cancer[J]. Eur Radiol,2021,31:3983-3992
the data analysis. YUAN Mei was responsible for the overall
[11]MIAO H,SHAOLEI L,NAN L,et al. Occult mediastinal
guidance of the research and the revision and improvement of
lymph node metastasis in FDG ⁃ PET/CT node ⁃ negative
the manuscript.
lung adenocarcinoma patients:risk factors and histopatho⁃
[参考文献]
logical study[J]. Thoracic Cancer,2019,10(6):1453-
[1] BRAY F,LAVERSANNE M,SUNG H,et al. Global can⁃ 1460
cer statistics 2022:GLOBOCAN estimates of incidence [12]ZHANG H,HUANG W,LIU C,et al. The prognostic val⁃
and mortality worldwide for 36 cancers in 185 countries[J]. ue of non⁃predominant micropapillary pattern in a large

